 | Cytosorbents Co. (NASDAQ:CTSO) to Post Q3 2021 Earnings of ($0.16) Per Share, B. Riley Forecasts
americanbankingnews.com - October 18 at 1:26 AM |
| Invo Bioscience (OTCMKTS:IVOB) vs. Cytosorbents (NASDAQ:CTSO) Head-To-Head Contrast
americanbankingnews.com - October 16 at 11:20 AM |
 | CytoSorbents gets enrollment underway in DrugSorb-ATR STAR–T trial - Seeking Alpha
seekingalpha.com - October 14 at 1:37 PM |
| Cytosorbents (NASDAQ:CTSO) Earns Buy Rating from Analysts at B. Riley
americanbankingnews.com - October 14 at 8:52 AM |
 | CytoSorbents Announces First Patient Enrolled In U.S. STAR-T Pivotal Trial Evaluating the DrugSorb-ATR Antithrombotic Removal System To Remove Ticagrelor During Cardiothoracic Surgery - Benzinga
benzinga.com - October 14 at 8:36 AM |
 | First Patient Enrolled in U.S. STAR-T Pivotal Trial Evaluating the DrugSorb-ATR™ Antithrombotic Removal System to Remove Ticagrelor During Cardiothoracic Surgery
finance.yahoo.com - October 14 at 8:36 AM |
| Cytosorbents (NASDAQ:CTSO shareholders incur further losses as stock declines 23% this week, taking three-year losses to 44%
finance.yahoo.com - October 14 at 8:36 AM |
| Cytosorbents (NASDAQ:CTSO) Price Target Cut to $10.00
americanbankingnews.com - October 13 at 12:04 PM |
| $11.96 Million in Sales Expected for Cytosorbents Co. (NASDAQ:CTSO) This Quarter
americanbankingnews.com - October 12 at 2:02 AM |
| Cytosorbents Co. (NASDAQ:CTSO) Expected to Post Earnings of -$0.10 Per Share
americanbankingnews.com - October 10 at 9:16 PM |
 | What Kind Of Investors Own Most Of Cytosorbents Corporation (NASDAQ:CTSO)? - Nasdaq
nasdaq.com - October 10 at 1:34 PM |
|
| Cytosorbents (NASDAQ:CTSO) Rating Reiterated by SVB Leerink
americanbankingnews.com - October 10 at 9:48 AM |
| Cytosorbents: Endocarditis Trial Failed To Remove Risk In Heart Surgery Patients - Seeking Alpha
seekingalpha.com - October 8 at 8:53 AM |
 | Cytosorbents (CTSO) Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference - StreetInsider.com
streetinsider.com - October 7 at 7:20 PM |
| CTSO Oct 2021 12.500 call
finance.yahoo.com - September 29 at 2:16 AM |
 | Health insurers justify passing COVID treatment costs on to patients despite massive profits - Fortune
fortune.com - September 24 at 6:21 PM |
| CytoSorbents to Host International Webinar on the Worldwide Experience Using CytoSorb® in Critically Ill Patients with COVID-19
finance.yahoo.com - September 14 at 1:36 PM |
| CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR™ Antithrombotic Removal System During Urgent Cardiothoracic Surgery - Yahoo Finance
finance.yahoo.com - September 10 at 8:47 PM |
| CytoSorbents files IDE for U.S. trial on apixaban/rivaroxaban removal during cardiothoracic surgery - Seeking Alpha
seekingalpha.com - September 10 at 3:47 PM |
| CytoSorbents Announces Webinar Discussing Topline Results from the U.S. CTC Registry using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO) - Yahoo Finance
finance.yahoo.com - September 10 at 1:44 AM |
| CytoSorbents Announces Webinar Discussing Topline Results from the U.S. CTC Registry using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)
finance.yahoo.com - September 8 at 7:42 PM |
| A Look At The Intrinsic Value Of Cytosorbents Corporation (NASDAQ:CTSO)
finance.yahoo.com - September 8 at 2:41 PM |
| Cytosorbents (NASDAQ:CTSO) shareholders have earned a 12% CAGR over the last five years - Nasdaq
nasdaq.com - September 6 at 7:35 AM |
| Form 8-K Cytosorbents Corp For: Aug 30 - StreetInsider.com
streetinsider.com - September 2 at 2:44 AM |
| Intuit Reportedly In Talks To Buy Mailchimp For Around $10 Bln - Nasdaq
nasdaq.com - September 1 at 4:41 PM |
| Seelos Therapeutics Promotes Michael Golembiewski To CFO - Quick Facts - Nasdaq
nasdaq.com - September 1 at 4:41 PM |
| U.S. CTC Registry Shows High Survival Using CytoSorb In Critically Ill COVID-19 Patients On ECMO - Nasdaq
nasdaq.com - September 1 at 4:41 PM |
| CytoSorbents' Product Associated With High Survival In Critically Ill COVID-19 Patients
finance.yahoo.com - September 1 at 4:41 PM |
| Topline Results from CytoSorbents' U.S. CTC Multicenter Registry Demonstrate High Survival using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)
finance.yahoo.com - September 1 at 8:50 AM |
| Italy reports 53 coronavirus deaths on Monday, 4,257 new cases - Yahoo Finance
finance.yahoo.com - August 30 at 10:07 PM |
| CytoSorbents, Aferetica Launch Organ Perfusion System In Italy
finance.yahoo.com - August 30 at 5:06 PM |
| Cytosorbents (CTSO), Aferetica Launch PerSorb Adsorber and PerLife Organ Perfusion System in Italy - StreetInsider.com
streetinsider.com - August 30 at 8:34 AM |
|
| Looking into CytoSorbents's Return on Capital Employed - Benzinga
benzinga.com - August 20 at 4:55 PM |
| Second U.S. FDA Breakthrough Device Designation Granted to CytoSorbents' DrugSorb-ATR™ Antithrombotic Removal System Adding the Removal of Market-Leading Direct Oral Anticoagulants During Urgent Cardiothoracic Surgery
finance.yahoo.com - August 12 at 4:33 PM |
| CytoSorbents Q2 Earnings Lag Consensus, Higher Costs Weigh On Bottom Line - Yahoo Finance
finance.yahoo.com - August 4 at 2:47 PM |
| CytoSorbents Q2 Earnings Lag Consensus, Higher Costs Weigh On Bottom Line
finance.yahoo.com - August 4 at 2:46 PM |
| CytoSorbents Q2 Earnings Lag Consensus, Higher Costs Weigh On Bottom Line - Benzinga
benzinga.com - August 4 at 9:46 AM |
| CytoSorbents Reports Second Quarter 2021 Financial and Operational Results
finance.yahoo.com - August 3 at 6:41 PM |
| Could The Cytosorbents Corporation (NASDAQ:CTSO) Ownership Structure Tell Us Something Useful? - Yahoo Finance
finance.yahoo.com - August 3 at 1:41 PM |
 | The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business - Markets Insider
markets.businessinsider.com - August 3 at 8:41 AM |
| Could The Cytosorbents Corporation (NASDAQ:CTSO) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - August 3 at 8:41 AM |
| CytoSorbents Sponsored Study Titled 'Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T) (STAR-T)' Posted To ClinicalTrials.Gov; Study Not Yet Recruiting - Benzinga
benzinga.com - July 26 at 5:31 PM |
| Cytosorbents Corporation Common Stock (CTSO)
nasdaq.com - July 25 at 7:44 PM |
| Insights Extracorporeal Membrane Oxygenation Machine Global Market to 2025 - Miniaturization of ECMO Machines Presents Opportunities - ResearchAndMarkets.com - Yahoo Finance Australia
finance.yahoo.com - July 23 at 9:48 AM |
| CytoSorbents to Report Second Quarter 2021 Operating and Financial Results - Yahoo Finance
finance.yahoo.com - July 19 at 10:13 AM |
| CytoSorbents to Report Second Quarter 2021 Operating and Financial Results
finance.yahoo.com - July 19 at 10:13 AM |
| Form S-3 Cytosorbents Corp - StreetInsider.com
streetinsider.com - July 15 at 2:20 PM |
| Drinkworks by Keurig's ready to dispense cocktails continue growth amid reopening - Yahoo Finance
finance.yahoo.com - July 7 at 6:06 PM |
| New Zealand health regulator approves use of Janssen COVID-19 vaccine - Yahoo Finance
finance.yahoo.com - July 7 at 8:05 AM |
| Cytosorbents (CTSO) Receives Full FDA Approval of IDE for US STAR-T Trial on Ticagrelor Removal During Cardiothoracic Surgery - StreetInsider.com
streetinsider.com - July 7 at 8:05 AM |
